As of Friday, January 30, Apogee Therapeutics, Inc.’s APGE share price has dipped by 7.75%, which has investors questioning ...

NAMM 2026: Where were you when we were getting high-gain mic preamps and realtime processing on every channel?

Shares of Apogee Therapeutics slid after stakeholder Fairmount Funds Management sold a portion of its holdings for $133.5 million. The stock was down 12% to $69.90 at midday on Friday. Shares have ...

Apogee Enterprises, Inc. (Nasdaq: APOG) announced today that Mark Augdahl has been appointed Executive Vice President and Chief Financial Officer, effective immediately. Mr. Augdahl has served as the ...

Investors in Apogee Enterprises, Inc. APOG need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $50 Put had some of the highest ...

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

Apogee Therapeutics filed a $100 million initial public offering late last week and with it a plan to compete against Dupixent, one of the pharma world’s top-selling anti-inflammatory drugs. The ...

The ed-tech company Apogee, which sells IT services to higher education, has unveiled new software and services aimed at helping colleges and universities manage data in the cloud, as schools continue ...

Reinforcing its commitment to expansion and growth in the competitive multifamily construction industry, APOGEE INTERIOR SOLUTIONS is proud to announce the appointment of two seasoned executives to ...

Apogee Enterprises appointed Mark Augdahl its executive vice president and chief financial officer, effective immediately. Augdahl has been the company's interim CFO since Jan. 7. The company, which ...